Evidence map›Paper›PMID 1420877›Full record

ArticleBiophysical journal1992

Implications of epidermal growth factor (EGF) induced egf receptor aggregation.

C Wofsy, B Goldstein, K Lund, H S Wiley

Open access · bronzeAbstract read
In one paragraph

Article in Biophysical journal, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. The EGFR family: not so prototypical receptor tyrosine kinases.Cold Spring Harbor perspectives in biology · 2014
    Review
  13. Article
  14. Article
  15. Dynamically varying interactions between heregulin and ErbB proteins detected by single-molecule analysis in living cells.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  16. Negative co-operativity in the EGF receptor.Biochemical Society transactions · 2012
    Article
  17. Article
  18. Article
  19. Article
  20. Ligand-induced ErbB receptor dimerization.Experimental cell research · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

C WofsyDepartment of Mathematics and Statistics, University of New Mexico, Albuquerque 87131.
B Goldstein
K Lund
H S Wiley
Los Alamos National Laboratory · USUniversity of New Mexico · US

Funding

Receptor Aggregation and Its EffectsR37GM035556 · NIGMS · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI GOLDSTEIN, BYRON B · 2003 to 2012
$6.4M
RECEPTOR AGGREGATION AND ITS EFFECTSR01GM035556 · NIGMS · UNIVERSITY OF CALIF-LOS ALAMOS NAT LAB · PI GOLDSTEIN, BYRON B · 1985 to 2002
$1.2M
NIGMS NIH HHS GM35556
6 · The paper itself

Abstract

To investigate the role of receptor aggregation in EGF binding, we construct a mathematical model describing receptor dimerization (and higher levels of aggregation) that permits an analysis of the influence of receptor aggregation on ligand binding. We answer two questions: (a) Can Scatchard plots of EGF binding data be analyzed productively in terms of two noninteracting receptor populations with different affinities if EGF induced receptor aggregation occurs? No. If two affinities characterize aggregated and monomeric EGF receptors, we show that the Scatchard plot should have curvature characteristic of positively cooperative binding, the opposite of that observed. Thus, the interpretation that the high affinity population represents aggregated receptors and the low affinity population nonaggregated receptors is wrong. If the two populations are interpreted without reference to receptor aggregation, an important determinant of Scatchard plot shape is ignored. (b) Can a model for EGF receptor aggregation and EGF binding be consistent with the "negative curvature" (i.e., curvature characteristic of negatively cooperative binding) observed in most Scatchard plots of EGF binding data? Yes. In addition, the restrictions on the model parameters required to obtain negatively curved Scatchard plots provide new information about binding and aggregation. In particular, EGF binding to aggregated receptors must be negatively cooperative, i.e., binding to a receptor in a dimer (or higher oligomer) having one receptor already bound occurs with lower affinity than the initial binding event. A third question we consider is whether the model we present can be used to detect the presence of mechanisms other than receptor aggregation that are contributing to Scatchard plot curvature. For the membrane and cell binding data we analyzed, the best least squares fits of the model to each of the four data sets deviate systematically from the data, indicating that additional factors are also important in shaping the binding curves. Because we have controlled experimentally for many sources of receptor heterogeneity, we have limited the potential explanations for residual Scatchard plot curvature.

Indexed as

AnimalsBinding SitesBiophysical PhenomenaBiophysicsEpidermal Growth FactorErbB ReceptorsKineticsL CellsMiceModels, BiologicalMutationProtein ConformationEpidermal Growth FactorErbB Receptors

Identifiers

PMID1420877
PMCPMC1262128
OpenAlexW2030090441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.